Smith & Nephew acquired BST-CarGel® cartilage repair product and IP assets from Piramal. Transaction terms were not disclosed.
Vexim initiated a new clinical study in France to compare 1-year and 2-year follow-up of SpineJack® vs. bracing in 100 acute traumatic vertebral compression fracture patients.
BioPoly was issued an additional U.S. patent pertaining to partial resurfacing implant designs and method of implantation.
Bio2 Technologies received FDA 510(k) clearance to market a fusion system for interphalangeal fusion, fracture repair and osteotomies of toes, fingers and other small bones. Limited product launch is slated for 2Q16.
MiMedx signed a definitive agreement to acquire Stability Biologics for US $10MM in cash and stock. Stability Biologics provides human tissue products for the surgical, spine and orthopaedic industries. The transaction is expected to close in early 1Q16.
CartiHeal completed a US $15MM financing round. Funds will support ongoing manufacturing scale-up, EU product commercialization in 2017 and clinical studies in new therapeutic areas for Agili-C™ cartilage regeneration technology.
BONESUPPORT announced the milestone of >20,000 patients treated worldwide to date with CERAMENT™ injectable drug-eluting bone substitute products.
K2M confirmed the first surgical case performed using the CASCADIA™ Lateral Interbody System featuring Lamellar Titanium Technology™, in late 4Q15.
Intellijoint Surgical received FDA 510(k) clearance to market the next-generation intellijioint HIP™ surgical smart tool, now including cup position (inclination and anteversion).
Vexim achieved a milestone of 25,000 SpineJack® units sold since market launch in 2011.